December 13, 2019 — Timpanogos Cancer Services made history in Utah recently with the installation of the state's first Radixact System, the next-generation tomotherapy platform. Accuray Incorporated's Radixact System is one of the most versatile systems available, enabling the administration of radiation using a range of delivery methods including image-guided, intensity-modulated radiation therapy (IG-IMRT) and stereotactic body radiation therapy (SBRT), that provide the hospital's clinical team with the flexibility to offer a personalized and precise treatment approach to almost anyone requiring treatment with radiation.
Timpanogos Cancer Services is part of the MountainStar Healthcare family of hospitals, a division of Hospital Corporation of America (HCA). Being part of this vast, nearly 300-hospital network helps Timpanogos Regional Hospital to achieve its goal of offering the highest quality of care to its patients.
Following a ribbon-cutting ceremony to commemorate the Radixact System installation, James W. Clarke M.D., a board certified radiation oncologist and Timpanogos Cancer Services director, shared how he believes the system will benefit the hospital's patients. "The Radixact System will enable our team to truly provide our patients with the best treatment for them. The treatment planning and delivery capabilities of the system allow for the highest level of precision with maximal sparing of the nearby normal tissues. The system's unique hardware and software will facilitate the treatment of organ-confined tumors, locally advanced tumors and metastatic tumors. It will also provide us with the tools to assess whether adaptation of radiation delivery during the course of treatment is needed because of changes in tumor size and patient anatomy. We look forward to using the Radixact System to efficiently deliver precise and accurate radiation treatments to more patients each day."
"We are proud to have the opportunity to partner with the Timpanogos Cancer Services clinical team to help advance cancer care in Utah. The response from our Radixact System users has been overwhelmingly positive as they have been able to expand patient access to precision radiation therapy, enabling previously untreatable cases to be treated with ease – and with a single, seamless process," said Joshua H. Levine, president and CEO at Accuray. "The unique Radixact System technology facilitates the delivery of both conventionally fractionated and hypofractionated radiation therapy treatments on a single platform, enabling the clinical team to treat a wide range of cancer cases. We believe this will be extremely valuable as reimbursement models shift favoring hypofractionation, when clinically appropriate. With the installation of the Radixact System, the Timpanogos team is well positioned to achieve their goal of providing world class radiation therapy treatments to their growing patient base."
For more information: www.accuray.com
July 14, 2025 
